Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy

American Journal of Pathology

Volumn 155, Issue 5, 1999, Pages 1651-1660

  Schmidt, Robert E ^a   Dorsey, Denise A ^a   Beaudet, Lucie N ^a   Plurad, Santiago B ^a   Parvin, Curtis A ^a   Miller, Matthew S ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETIC NEUROPATHY; GANGLION; INSULIN TREATMENT; INTESTINE INNERVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

EID: 0032704457     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65480-6     Document Type: Article

References (76)

1. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort. Neurology 1993, 43:817-824
2. Vinik AI, Holland MT, LeBeau JM, Liuzzi FJ, Stansberry KB, Colen LB: Diabetic neuropathies. Diabetes Care 1992, 15:1926-1975
3. Bundles RW: Diabetic neuropathy: general review with report of 125 cases. Medicine (Baltimore) 1945, 24:111-160
4. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med 1980, 49:95-108
5. Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ: Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 1990, 278:635-646
6. Hoffman RP, Sinkey CA, Kienzle MG, Anderson E: Muscle sympathetic nerve activity is reduced in IDDM before overt autonomic neuropathy. Diabetes 1993, 42:375-380
7. 123l]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Diabetes 1995, 44:543-549
8. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA: Complications neuropathy, pathogenetic considerations. Diabetes Care 1992, 15:1902-1925
9. Zochodne DW: Diabetic neuropathies: features and mechanisms. Brain Pathol 1999, 9:369-391
10. Greene DA, Lattimer S, Ulbrecht J, Carroll P: Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 1985, 8:290-299
11. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988, 318:1315-1321
12. Low PA, Nickander KK, Tritschler HJ: The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997, 46(Suppl 2):S38-S42
13. Low PA, Nickander KK, Scionti L: Role of hypoxia, oxidative stress, and excitatory neurotoxins in diabetic neuropathy. Diabetic Neuropathy. Edited by PJ Dyck, PK Thomas, Philadelphia, WB Saunders, 1999, pp 317-329
14. Fernyhough P, Gallagher A, Averill SA, Priestley JV, Hounsom L, Patel J, Tomlinson DR: Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 1999, 48:881-889
15. Rabinowe SL, Brown FM, Watts M, Smith AM: Complement-fixing antibodies to sympathetic and parasympathetic tissues in IDDM. Diabetes Care 1990, 13:1084-1088
16. Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D: Retrograde axonal transport of transmitter enzymes, lucose-labelled protein and nerve growth factor in streptozotocin-diabetic rats. Diabetes 1981, 30:797-803
17. 125l-nerve growth factor in rats with streptozotocin-induced diabetes. Diabetes 1983, 32:654-663
18. Hellweg R, Hartung H-D: Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role tor NGF in the pathogenesis of diabetic neuropathy, J Neurosci Res 1990, 26:258-267
19. Hellweg R, Wohrle M, Hartung H-D, Stracke H, Hock C, Federlin K: Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantation. Neurosci Lett 1991, 125:1-4
20. Fernyhough P, Diemel LT, Tomlinson DR: Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 1998, 41:300-306
21. Brewster WJ, Fernyhough P, Diemel LT, Mohiuddin L, Tomlinson DR: Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 1995, 18:15-18
22. Apfel SC: Neurotrophic factors and diabetic peripheral neuropathy. Eur Neurol 1999, 41(Suppl 1):27-34
23. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddin L, Tomlinson DR: Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci 1995, 7:1107-1110
24. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR: Expression of neuropeptides in experimental diabetes: effects of treatment with nerve growth factor or brain derived neurotrophic factor. Mol Brain Res 1994, 21:171-175
25. Schmidt RE, Plurad SB: Ultrastructural and biochemical characterization of autonomic neuropathy in rats with chronic streptozotocin diabetes. J Neuropathol Exp Neurol 1986, 45:525-544
26. Schmidt RE, Cogswell BE: Tyrosine hydroxylase activity in sympathetic nervous system of rats with streptozocin-induced diabetes. Diabetes 1989, 38:959-968
27. Schroer JA, Beaudet LN. Schmidt RE: Effect of chronic autoimmune nerve growth factor deprivation on sympathetic neuroaxonal dystrophy in rats. Synapse 1995, 20:249-256
28. Recio-Pinto E, Rechler MM, Ishii DN: Effects of insulin, insulin-like growth factor-II, and nerve growth factor in neurite formation and survival in cultured sympathetic and sensory neurons. J Neurosci 1986, 6:1211-1219
29. Fernyhough P, Willars GB, Lindsay RM, Tomlinson DR: Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurons. Brain Res 1993, 607:117-124
30. Ishii DN: Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Rev 1995, 20:47-67
31. Wuarin L, Guertin DM, Ishii DN: Early reduction in insulin-like growth factor gene expression in diabetic nerve. Exp Neurol 1994, 130:106-114
32. Zhuang H-X, Snyder CK, Pu S-F. Ishii DN: Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol 1996, 140:198-205
33. Bornfeldt KE, Arnqvist HJ, Enberg B, Mathews LS, Norstedt G: Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol 1989, 122:651-656
34. Singhal A, Cheng C, Sun H, Zochodne DW: Near nerve local insulin treatment prevents conduction abnormalities in experimental diabetes. Brain Res 1997, 763:209-214
35. Sima AAF, Merry AC, Levitan I: Increased regeneration in ARI-treated diabetic nerve is associated with upregulation of IGF-I and NGF receptors. Exp Clin Endocrinol Diabetes 1997, 105:60-62
36. Longo FM, Powell HC, Lebeau J, Gerrero MR, Heckman H, Myers RR: Delayed nerve regeneration in streptozotocin diabetic rats. Muscle Nerve 1986, 9:385-393
37. Ekstrom PAR, Kanje M, Skottner A: Nerve regeneration and serum levels of insulin-like growth factor-I in rats with streptozotocin-induced deficiency. Brain Res 1989, 496:141-147
38. Migdalis IN, Kalogeropoulou, Kalantzis L, Nounopoulos C, Bouloukos, Samartzis M: Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy. Diabetes Med 1995, 12:823-827
39. Schmidt RE, Plurad SM, Modert CW: Experimental diabetic autonomic neuropathy-characterization in streptozotocin-diabetic Sprague-Dawley rats. Lab Invest 1983, 49:538-552
40. Schmidt RE: The neuropathology of human sympathetic autonomic ganglia, Microsc Res Tech 1996, 35:107-121
41. Schmidt RE, Plurad SB, Parvin CA, Roth KA: The effect of diabetes and aging on human sympathetic autonomic ganglia. Am J Pathol 1993, 143:143-153
42. Yagihashi S, Sima AAF: The distribution of structural changes in sympathetic nerves of the BB rat. Am J Pathol 1985, 121:138-147
43. Schmidt RE, Nelson JS, Johnson EM Jr: Experimental diabetic autonomic neuropathy. Am J Pathol 1981, 103:210-225
44. Schmidt RE, Plurad SB, Olack BJ, Scharp DW: The effect of pancreatic islet transplantation and insulin therapy on experimental diabetic autonomic neuropathy. Diabetes 1983, 32:532-540
45. Schmidt RE, Plurad SB, Olack BJ, Scharp DW: The effect of pancreatic islet transplantation and insulin therapy on neuroaxonal dystrophy in sympathetic autonomic ganglia of chronic streptozocin-diabetic rats. Brain Res 1989, 497:393-398
46. Schmidt RE, Plurad SB, Coleman BD, Williamson JR, Tilton RG: Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats. Diabetes 1991, 40:574-582
47. Scott LD, Ellis TM: Small intestinal transit and myoelectric activity in diabetic rats. Gastrointestinal Motility. Edited by J Christensen. New York, Raven Press, 1980, pp 395-399
48. Chang EM, Fedorak RN, Field M: Experimental diabetic diarrhea in rats. Intestinal mucosal denervation hypersensitivity and treatment with clonidine. Gastroenterology 1986, 91:364-369
49. Schmidt RE, Dorsey DA, Beaudet LN, Plurad SB, Williamson JR, Ido Y: Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy. J Neuropathol Exp Neurol 1998, 57: 1175-1189
50. SAS Institute: SAS User's Guide: The NPAR1WAY Procedure: Statistics, Version 5, ch 26. Cary, NC, SAS Institute, 1985, pp 607-614
51. Schmidt RE, Plurad SB, Modert CW: Neuroaxonal dystrophy in the autonomic ganglia of aged rats. J Neuropathol Exp Neurol 1983, 42:376-390
52. Hansson H-A, Rozell B, Skottner A: Rapid axoplasmic transport of insulin-like growth factor-I in the sciatic nerve of adult rats. Cell Tissue Res 1987, 247:241-247
53. Karagiannis SN, King RHM, Thomas PK: Colocalization of insulin and IGF-I receptors in cultured rat sensory and sympathetic ganglion cells. J Anat 1997, 191:431-440
54. Bitar MS, Pilchher CWT, Khan I, Waldbillig RJ: Diabetes-induced suppression of IGF-I and its receptor mRNA levels in rat superior cervical ganglia. Diabetes Res Clin Pract 1997, 38:73-80
55. Crosby SR, Tsigos C, Anderton CD, Gordon C, Young RJ, White A: Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy. Diabetologia 1992, 35:868-872
56. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995, 16:3-34
57. Gorio A, Vergani L, De Tollis A, Di Giulio, Torsello A, Cattaneo L, Muller EE: Muscle reinnervation following neonatal nerve crush. Interactive effects of glycosaminoglycans and insulin-like growth factor. Neuroscience 1998, 82:1029-1037
58. Blair LAC, Bence-Hanulec KK, Mehta S, Franke T, Kaplan D, Marshall J: Akt-dependent potentiation of L channels by insulin-like growth factor-1 is required for neuronal survival. J Neurosci 1999, 19:1940-1951
59. Wang C, Li Y, Wible B, Angelides KJ, Ishii DN: Effects of insulin and insulin-like growth factors on neurofilament mRNA and tubulin mRNA content in human neuroblastoma SH-SY5Y cells. Mol Brain Res 1992, 13:289-300
60. Schmidt RE: Synaptic dysplasia in sympathetic autonomic ganglia. J Neurocytol 1996, 25:777-791
61. Ishii DN, Glazner GW, Pu SF: Role of insulin-like growth factors in peripheral nerve regeneration. Pharmacol Ther 1994, 62:125-144
62. Cheng H-L, Randolph A, Yee D, Delafontaine P, Tennekoon G, Feldman EL: Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. J Neurochem 1996, 66:525-536
63. Ishii DN, Glazner GW, Whalen LR: Regulation of peripheral nerve regeneration by insulin-like growth factors. Ann NY Acad Sci 1993, 692:172-182
64. Dore S, Kar S, Quirion R: Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci 1997, 20:326-331
65. Hansson H-A: Insulin-like growth factors and nerve regeneration. Ann NY Acad Sci 1993, 692:161-171
66. Gloster A, Diamond J: Sympathetic nerves in adult rats regenerate normally and restore pilomotor function during an anti-NGF treatment that prevents collateral sprouting. J Comp Neural 1992, 326:363-374
67. Ishii DN, Lupien SB: Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats. J Neurosci Res 1995, 40:138-144
68. Engber TM, Bhat RV, Dennis SA, Miller M, Contreras PC: Effects of IGF-I infusion on serum IGF binding proteins and functional recovery following sciatic nerve crush. Soc Neurosci Abstr 1995, 21:1549
69. Caroni P, Becker M: The downregulation of growth-associated proteins in motoneurons at the onset of synapse elimination is controlled by muscle activity and IGF-I. J Neurosci 1992, 12:3849-3861
70. Rabinovsky ED, Kattash MM, Shenaq SM, DeMayo F, Schwartz R: The role of IGF-I in peripheral nerve regeneration: studies in IGF-I transgenic mice. Soc Neurosci Abstr 1996, 22:1960
71. Near SL, Whalen LR, Miller JA, Ishii DN: Insulin like growth factor II stimulates motor nerve regeneration. Proc Natl Acad Sci USA 1992, 89:11716-11720
72. Tan K, Baxter RC: Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age. J Clin Endocrinol Metab 1986, 63:651-655
73. Schmidt RE, Plurad DA, Plurad SB, Cogswell BE, Diani AR, Roth KA: Ultrastructural and immunohistochemical characterization of autonomic neuropathy in genetically diabetic Chinese hamsters. Lab Invest 1989, 61:77-92
74. Camilleri M, Malagelada J-R: Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984, 14:420-427
75. Battle WM, Snape WJ. Alavi A, Cohen S, Braunstein S: Colonic dysfunction in diabetes mellitus. Gastroenterology 1980, 79:1217-1221
76. Duchen LW, Anjorin A, Watkins PJ, MacKay JD: Pathology of autonomic neuropathy in diabetes. Ann Intern Med 1980, 92:301-303